YKL-40 is an inflammatory biomarker linked to tumour progression in various cancers, and its levels are consistently elevated in patients with T2D, a condition linked to increased risks for multiple ...
Growing body of clinical and real-world evidence supports the role of Rezdiffra® (resmetirom) as the foundational therapy for patients with MASH ...
Roche introduces the first comprehensive library of certified healthcare algorithms to support chronic liver disease (CLD) management The Liver Disease Panel includes LiverPRO—a certified algorithm ...
Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for approximately 90% of all liver cancer cases. Given that the development ...
Characteristics of HPR and influence on patient prognosis. (A) Flow chart of patient enrollment. (B) Representative pattern diagram and image of two types of HPR. (C) Graph of HPR occurrence times. (D ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Diagnosing liver cancer may have just gotten more straightforward, ...
Using spatial multi-omics, researchers identified shifting macrophage populations in MASLD progression, identifying markers to aid patient stratification in clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results